Source: Virtual Congress 2021 – Emerging respiratory diseases: state-of-the-art studies of SARS-CoV-2 infection



Rating:

Share or cite this content

Citations should be made in the following way:
R. Sana (South San Francisco, United States of America), E. Gordon (South San Francisco, United States of America), A. Navratil (South San Francisco, United States of America), E. Sandvik (South San Francisco, United States of America), J. Woo (South San Francisco, United States of America), R. Saggar (South San Francisco, United States of America), E. Moran (South San Francisco, United States of America), E. Kaufman (South San Francisco, United States of America). TD-0903, an inhaled JAK inhibitor in development for COVID-19, blocks ARDS-relevant hyperinflammation and lung injury in primary human immune and airway epithelial cells. 4304

Member's Comments

No comment yet.

Related content which might interest you: The potent and lung-selective inhaled pan JAK inhibitor TD-8236 limits airway inflammation without affecting systemic immunity in mice Source: International Congress 2019 – Novel targets and mechanisms in asthma Year: 2019 Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells Source: Eur Respir J 2012; 39: 439-445 Year: 2012 The immunomodulator, FTY720, leads to sequestration of T cells in the bronchial associated lymphoid tissue (BALT) and inhibits allergen-induced airway remodeling Source: Annual Congress 2010 - Asthma: basic science and clinical studies Year: 2010 HDAC inhibitors may regulate EMT and surfactant protein C in human alveolar epithelial cells Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 The pan janus kinase (JAK) inhibitor KN-002 suppresses inflammatory mediator release from severe asthma bronchial epithelial cells. Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 Protective effect of MAPK inhibitors and budesonide against apoptosis induced by TGF-β in primary cultures of human bronchial epithelial cells Source: Eur Respir J 2003; 22: Suppl. 45, 394s Year: 2003 Stem cell therapy attenuates airway and lung parenchyma remodeling in a murine model of chronic allergic asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008 Effects of ciclesonide (CIC) on human adult lung fibroblasts functions involved in airway inflammation and remodeling Source: Eur Respir J 2006; 28: Suppl. 50, 101s Year: 2006 B cells in different stages of development increase in the lung in a murine model of airway allergic inflammation Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009 Preferential activation of alveolar macrophages versus epithelial cells during initiation of ventilator-induced lung injury in mice Source: Annual Congress 2011 - Lung cell injury and repair Year: 2011 IL-25 secreted from epithelial cells has the potential to promote airway remodeling in asthma Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms Year: 2012 The use of alveolar epithelial type I cell-selective markers to investigate lung injury and repair Source: Eur Respir J 2004; 24 : 664-673 Year: 2004 Role of alveolar epithelial ICAM-1 in lipopolysaccharide-induced lung inflammation Source: Eur Respir J 2002; 19: 1142-1150 Year: 2002 The innate immune function of airway epithelial cells in inflammatory lung disease Source: Eur Respir J 2015; 45: 1150-1162 Year: 2015 Postconditioning with a volatile anaesthetic in alveolar epithelial cells in vitro Source: Eur Respir J 2008; 31: 118-125 Year: 2008 A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 568s Year: 2002 Altered phenotype of COPD primary fibroblasts from airway and alveolar tissues: proliferation and apoptosis. Source: International Congress 2019 – Research and innovation in airway diseases Year: 2019 PBI-4050 reduces expression of fibrosis biomarkers in the BioMAP SAEMyoF primary human small airway epithelial cells and lung myofibroblasts system Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017 Apoptotic cell instillation after bleomycin attenuates lung injury through hepatocyte growth factor induction Source: Eur Respir J 2012; 40: 424-435 Year: 2012